J Mac McCullough1, Frederick J Zimmerman2, Hector P Rodriguez3. 1. School for the Science of Health Care Delivery, Arizona State University, Phoenix, Arizona, USA. 2. Department of Health Policy and Management, University of California, Los Angeles Fielding School of Public Health, Los Angeles, California, USA. 3. Department of Health Policy and Management, University of California, Berkeley School of Public Health, Berkeley, California, USA.
Abstract
OBJECTIVE: Antibiotics are commonly recognized as non-indicated for acute bronchitis and upper respiratory tract infection (URI), yet their widespread use persists. Clinical decision support in the form of electronic warnings is hypothesized to prevent non-indicated prescriptions. The purpose of this study was to identify the effect of clinical decision support on a common type of non-indicated prescription. MATERIALS AND METHODS: Using National Ambulatory Medical Care Survey data from 2006 to 2010, ambulatory visits with a primary diagnosis of acute bronchitis or URI and orders for antibiotic prescriptions were identified. Visits were classified on the basis of clinician report of decision-support use. Generalized estimating equations were used to assess the effect of decision support on likelihood of antibiotic prescription receipt, controlling for patient, provider, and practice characteristics. RESULTS: Clinician use of decision support increased sharply between 2006 (16% of visits) and 2010 (55%). Antibiotic prescribing for acute bronchitis and URI increased from ∼35% of visits in 2006 to ∼45% by 2010. Use of decision support was associated with a 19% lower likelihood of receiving an antibiotic prescription, controlling for patient, provider, and practice characteristics. DISCUSSION: In spite of the increased use of decision-support systems and the relatively fewer non-indicated antibiotic prescriptions resulting from the use of decision support, a secular upward trend in non-indicated antibiotic prescribing offset these improvements. CONCLUSIONS: The overall effect of decision support suggests an important role for technology in reducing non-indicated prescriptions. Decision support alone may not be sufficient to eliminate non-indicated prescriptions given secular trends. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
OBJECTIVE: Antibiotics are commonly recognized as non-indicated for acute bronchitis and upper respiratory tract infection (URI), yet their widespread use persists. Clinical decision support in the form of electronic warnings is hypothesized to prevent non-indicated prescriptions. The purpose of this study was to identify the effect of clinical decision support on a common type of non-indicated prescription. MATERIALS AND METHODS: Using National Ambulatory Medical Care Survey data from 2006 to 2010, ambulatory visits with a primary diagnosis of acute bronchitis or URI and orders for antibiotic prescriptions were identified. Visits were classified on the basis of clinician report of decision-support use. Generalized estimating equations were used to assess the effect of decision support on likelihood of antibiotic prescription receipt, controlling for patient, provider, and practice characteristics. RESULTS: Clinician use of decision support increased sharply between 2006 (16% of visits) and 2010 (55%). Antibiotic prescribing for acute bronchitis and URI increased from ∼35% of visits in 2006 to ∼45% by 2010. Use of decision support was associated with a 19% lower likelihood of receiving an antibiotic prescription, controlling for patient, provider, and practice characteristics. DISCUSSION: In spite of the increased use of decision-support systems and the relatively fewer non-indicated antibiotic prescriptions resulting from the use of decision support, a secular upward trend in non-indicated antibiotic prescribing offset these improvements. CONCLUSIONS: The overall effect of decision support suggests an important role for technology in reducing non-indicated prescriptions. Decision support alone may not be sufficient to eliminate non-indicated prescriptions given secular trends. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Entities:
Keywords:
Acute bronchitis; Antibiotics; Health information technology
Authors: R Gonzales; J G Bartlett; R E Besser; R J Cooper; J M Hickner; J R Hoffman; M A Sande Journal: Ann Intern Med Date: 2001-03-20 Impact factor: 25.391
Authors: Devin Mann; Rachel Hess; Thomas McGinn; Safiya Richardson; Simon Jones; Joseph Palmisano; Sara Kuppin Chokshi; Rebecca Mishuris; Lauren McCullagh; Linda Park; Catherine Dinh-Le; Paul Smith; David Feldstein Journal: J Gen Intern Med Date: 2020-09-01 Impact factor: 5.128
Authors: Heather Lyu; Tim Xu; Daniel Brotman; Brandan Mayer-Blackwell; Michol Cooper; Michael Daniel; Elizabeth C Wick; Vikas Saini; Shannon Brownlee; Martin A Makary Journal: PLoS One Date: 2017-09-06 Impact factor: 3.240
Authors: Marcia Vervloet; Marianne A Meulepas; Jochen W L Cals; Mariëtta Eimers; Lucas S van der Hoek; Liset van Dijk Journal: NPJ Prim Care Respir Med Date: 2016-02-04 Impact factor: 2.871